European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
Overview
The European Journal of Pharmaceutical Sciences is the official journal of the European Federation for Pharmaceutical Sciences. It publishes high-quality research articles, reviews, and commentaries in the field of pharmaceutical sciences. The journal covers a wide range of topics including drug discovery, drug delivery systems, pharmacokinetics, and pharmaceutical technology. It serves as a platform for researchers, scientists, and professionals to share their latest findings and advancements in the pharmaceutical field.
Details
Details
Abbr.
Eur J Pharm Sci
Start
1993
End
Continuing
Frequency
Fifteen no. a year, 2001-
p-ISSN
0928-0987
e-ISSN
1879-0720
Country
Netherlands
Language
English
Specialties
Pharmacology
Chemistry
Chemistry
Metrics
Metrics
h-index / Ranks: 1195
163
SJR / Ranks: 5768
752
CiteScore / Ranks: 1714
9.20
JIF / Ranks: 1820
4.6
Recent Articles
1.
Tuomi S, Deng F, Neuvonen M, Niemi M
Eur J Pharm Sci
. 2025 Mar;
:107070.
PMID: 40089121
Statins are widely used in the treatment of hypercholesterolemia but also associated with muscle-related adverse effects. Multidrug resistance-associated protein (MRP) 1 and 5 are expressed in the skeletal muscle, where...
2.
Zegota M, Achenbach J, Schuster G, Schoneich C, Menzen T, Hawe A
Eur J Pharm Sci
. 2025 Mar;
:107065.
PMID: 40086702
The non-ionic surfactants polysorbate 20, polysorbate 80 and poloxamer 188 are prone to degradation, which necessitates their monitoring as part of the analytical strategy for surfactant- containing biopharmaceuticals. In this...
3.
Okada R, Shibata K, Shibuya R, Torisu T, Uchiyama S
Eur J Pharm Sci
. 2025 Mar;
208:107060.
PMID: 40086315
Physical stresses such as agitation induce protein aggregation, which causes adverse effects on the immune system of patients, leading to challenges in drug development. Aggregation induced by physical stresses can...
4.
Shahin M, Elyamani M, Elsawi A, Negmeldin A, Naguib S, Safwat H, et al.
Eur J Pharm Sci
. 2025 Mar;
:107062.
PMID: 40074018
In the current medical era, the proliferation and dissemination of drug-resistant strains of Mycobacterium tuberculosis continue to pose a significant worldwide health hazard, necessitating the development of new and innovative...
5.
Binder J, Zalar M, Huelsmeyer M, Siedler M, Curtis R, Friess W
Eur J Pharm Sci
. 2025 Mar;
:107068.
PMID: 40074017
Coarse-grained molecular dynamics simulations are highly valuable for studying protein-protein interactions. Unfortunately, commonly used force fields often overestimate these interactions. Here, we investigate the performance of the Martini 3 force...
6.
Lehner E, Trutschel M, Menzel M, Jacobs J, Kunert J, Scheffler J, et al.
Eur J Pharm Sci
. 2025 Mar;
209:107067.
PMID: 40068768
Poly(lactic-co-glycolic acid) (PLGA) is a prominent biodegradable polymer used in biomedical applications, including drug delivery systems (DDS) and tissue engineering. PLGA's ability to control drug release is often hindered by...
7.
Derobertmasure A, Toh L, Wotring V, Wotring V, Williams P, Morbidelli L, et al.
Eur J Pharm Sci
. 2025 Mar;
209:107063.
PMID: 40064402
Future long-duration crewed space missions beyond Low Earth Orbit (LEO) will bring new healthcare challenges for astronauts for which pharmacological countermeasures (pharmacological countermeasures) are crucial. This paper highlights current pharmacological...
8.
Poggialini F, Governa P, Vagaggini C, Maramai S, Lamponi S, Mugnaini C, et al.
Eur J Pharm Sci
. 2025 Mar;
:107066.
PMID: 40064401
The possibility to control the effects of drugs in time and space represents an ideal condition for developing safer and more personalized therapies against different disorders. In this context, photopharmacology...
9.
Albash R, Fahmy A, Shamsel-Din H, Ibrahim A, Bogari H, Malatani R, et al.
Eur J Pharm Sci
. 2025 Mar;
208:107061.
PMID: 40057137
The present work aimed to load propranolol hydrochloride (PN), a beta-blocking agent with low oral bioavailability, into PLGA-lipid hybrid nanoparticles (PLHNPs) for augmenting its efficacy. PLHNPs contain phospholipid (PC) in...
10.
Samani R, Mehrgardi M, Maghsoudinia F, Najafi M, Mehradnia F
Eur J Pharm Sci
. 2025 Mar;
:107059.
PMID: 40049297
The efficacy of radiation therapy can decrease due to the inherent radioresistance of different tumor cells. Gadolinium shows significant potential as a radiosensitivity enhancer due to its high atomic number....